Renate Kos

593 total citations
18 papers, 313 citations indexed

About

Renate Kos is a scholar working on Pulmonary and Respiratory Medicine, Biomedical Engineering and Physiology. According to data from OpenAlex, Renate Kos has authored 18 papers receiving a total of 313 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 4 papers in Biomedical Engineering and 3 papers in Physiology. Recurrent topics in Renate Kos's work include Cystic Fibrosis Research Advances (6 papers), Advanced Chemical Sensor Technologies (4 papers) and Respiratory and Cough-Related Research (3 papers). Renate Kos is often cited by papers focused on Cystic Fibrosis Research Advances (6 papers), Advanced Chemical Sensor Technologies (4 papers) and Respiratory and Cough-Related Research (3 papers). Renate Kos collaborates with scholars based in Netherlands, United Kingdom and Hungary. Renate Kos's co-authors include Frank A. Redegeld, Jing Chen, Johan Garssen, Anke H. Maitland‐van der Zee, Lieuwe D. J. Bos, Anne H. Neerincx, Eric G. Haarman, Paul Brinkman, Katerina Konstantoulea and Riccardo Stucchi and has published in prestigious journals such as Nature Communications, Frontiers in Pharmacology and Cells.

In The Last Decade

Renate Kos

15 papers receiving 309 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Renate Kos Netherlands 7 150 108 37 34 32 18 313
Darryl T. Martin United States 12 116 0.8× 76 0.7× 61 1.6× 15 0.4× 18 0.6× 27 339
Luocheng Li China 10 154 1.0× 50 0.5× 20 0.5× 33 1.0× 41 1.3× 20 345
Akihiro Nakamura Japan 11 235 1.6× 50 0.5× 36 1.0× 26 0.8× 35 1.1× 36 490
John R. Megill United States 7 143 1.0× 111 1.0× 28 0.8× 15 0.4× 26 0.8× 11 351
Jessica O’Rear United States 8 162 1.1× 63 0.6× 44 1.2× 33 1.0× 42 1.3× 8 563
Kaoru Otsuka Japan 14 174 1.2× 69 0.6× 31 0.8× 77 2.3× 54 1.7× 19 449
Aiping Duan China 8 207 1.4× 41 0.4× 33 0.9× 59 1.7× 22 0.7× 15 392
Li Yao China 10 200 1.3× 83 0.8× 12 0.3× 29 0.9× 52 1.6× 42 419

Countries citing papers authored by Renate Kos

Since Specialization
Citations

This map shows the geographic impact of Renate Kos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renate Kos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renate Kos more than expected).

Fields of papers citing papers by Renate Kos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Renate Kos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renate Kos. The network helps show where Renate Kos may publish in the future.

Co-authorship network of co-authors of Renate Kos

This figure shows the co-authorship network connecting the top 25 collaborators of Renate Kos. A scholar is included among the top collaborators of Renate Kos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Renate Kos. Renate Kos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Kos, Renate, Anne H. Neerincx, Suzanne W. J. Terheggen‐Lagro, et al.. (2024). Dried Blood Spot Method Development and Clinical Validation for the Analysis of Elexacaftor, Elexacaftor-M23, Tezacaftor, Tezacaftor-M1, Ivacaftor, Ivacaftor Carboxylate, and Hydroxymethyl Ivacaftor Using LC-MS/MS. Therapeutic Drug Monitoring. 46(6). 804–812. 3 indexed citations
2.
Ahmed, Waqar, Renate Kos, Stephen J. Fowler, et al.. (2023). Influence of bacterial and alveolar cell co-culture on microbial VOC production using HS-GC/MS. Frontiers in Molecular Biosciences. 10. 1160106–1160106. 4 indexed citations
3.
Kos, Renate, Anne H. Neerincx, Paul Brinkman, et al.. (2022). Real‐life efficacy and safety of elexacaftor/tezacaftor/ivacaftor on severe cystic fibrosis lung disease patients. Pharmacology Research & Perspectives. 10(6). e01015–e01015. 21 indexed citations
4.
Kos, Renate, Christine D. L. van Gogh, Josje Altenburg, et al.. (2022). Primary ciliary dyskinesia in Volendam: Diagnostic and phenotypic features in patients with a CCDC114 mutation. American Journal of Medical Genetics Part C Seminars in Medical Genetics. 190(1). 89–101. 7 indexed citations
5.
Abdel‐Aziz, Mahmoud I., Paul Brinkman, Renate Kos, et al.. (2021). Comparison of microbial composition of cough swabs and sputum for pathogen detection in patients with cystic fibrosis. Journal of Cystic Fibrosis. 21(1). 52–60. 13 indexed citations
6.
Kos, Renate, Paul Brinkman, Anne H. Neerincx, et al.. (2021). Targeted exhaled breath analysis for detection of Pseudomonas aeruginosa in cystic fibrosis patients. Journal of Cystic Fibrosis. 21(1). e28–e34. 28 indexed citations
7.
Kos, Renate, Anne H. Neerincx, Paul Brinkman, et al.. (2021). 563: Real-life initiation of elexacaftor/ivacaftor/tezacaftor in cystic fibrosis patients with severe lung disease. Journal of Cystic Fibrosis. 20. S265–S266. 1 indexed citations
8.
Ferrari, Luca, Riccardo Stucchi, Katerina Konstantoulea, et al.. (2020). Arginine π-stacking drives binding to fibrils of the Alzheimer protein Tau. Nature Communications. 11(1). 571–571. 44 indexed citations
9.
Kos, Renate, Joris D. Veltman, Wilma Uyterlinde, et al.. (2020). Comparison of Myelotoxicity and Nephrotoxicity Between Daily Low-Dose Cisplatin With Concurrent Radiation and Cyclic High-Dose Cisplatin in Non-Small Cell Lung Cancer Patients. Frontiers in Pharmacology. 11. 975–975. 5 indexed citations
10.
Kos, Renate, Paul Brinkman, Anne H. Neerincx, et al.. (2020). Targeted exhaled breath analysis for detection of Pseudomonas aeruginosa in cystic fibrosis patients. EUR Research Repository (Erasmus University Rotterdam). 685–685.
11.
Chen, Jing, Renate Kos, Johan Garssen, & Frank A. Redegeld. (2019). Molecular Insights into the Mechanism of Necroptosis: The Necrosome as a Potential Therapeutic Target. Cells. 8(12). 1486–1486. 145 indexed citations
12.
Kos, Renate, Rianne de Vries, Paul Brinkman, et al.. (2018). Detection of Pseudomonas aeruginosa infection in cystic fibrosis patients by eNose technology. PA3412–PA3412. 1 indexed citations
13.
Kos, Renate, et al.. (2000). Limb-saving surgery, survival, and prognostic factors for osteosarcoma: The Hungarian experience. Journal of Surgical Oncology. 73(2). 87–94. 30 indexed citations
14.
Kos, Renate, et al.. (1993). Proteinuria due to suboptimal hydration with high-dose methotrexate therapy. Cancer Chemotherapy and Pharmacology. 33(3). 262–263. 5 indexed citations
15.
Kos, Renate, et al.. (1984). Metabolism of fibrinogen in children with acute lymphoblastic leukaemia. European Journal of Pediatrics. 143(2). 140–144. 3 indexed citations
16.
Kos, Renate. (1967). Local corticosteroid therapy.. PubMed. 15(4). 171–2. 2 indexed citations
17.
Kos, Renate, et al.. (1963). [Current problems of antibiotic therapy in surgery].. PubMed. 16. 84–93.
18.
Kos, Renate, et al.. (1953). Intravenous anaesthesia in surgery.. PubMed. 2. 9–12. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026